Bilaero-M is listed as containing Bilastine 20 mg, a second-generation antihistamine. Bilastine selectively blocks peripheral histamine H1 receptors, helping address histamine-related symptoms in allergic conditions such as allergic rhinitis. The product is presented as an oral tablet in the Respiratory Range. Use should be guided by clinical assessment and the applicable product label; healthcare professionals should consider patient-specific factors when selecting treatment.
· Contains Bilastine 20mg + Montelukast 10mg
· Bilastine — non-sedating second-generation H1-antihistamine
· Montelukast — leukotriene receptor antagonist that blocks cysteinyl leukotrienes involved in airway inflammation and bronchoconstriction
· Presented as tablets
· Prescription-only medicine
· Allergic rhinitis
· Sneezing, runny or blocked nose and itchy, watery eyes
· Allergic rhinitis with asthma
· Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Should be taken away from food and fruit juice per label; caution with P-gp interactions in renal impairment.
· Montelukast carries a regulatory warning for neuropsychiatric events (including sleep disturbance, depression and suicidal thoughts); patients should report mood or behaviour changes.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of montelukast described here follow the US prescribing information (DailyMed). Evidence summary for Bilastine: reference verification pending. Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about Bilaero-M for professional use.